Tech Company Financing Transactions

MiRagen Therapeutics Funding Round

MSD Capital, Rally Ventures and Amgen Ventures participated in a $41 million Series C funding round for MiRagen Therapeutics. The round was recorded on 11/10/2015.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

6200 Lookout Rd. 100
Boulder, CO 80301
USA

Phone

(303) 531-5952

Website

www.miragentherapeutics.com

Email Address

[email protected]

Overview

Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

William Marshall

        

Chief Financial Officer

Jason Leverone

        

VP - Bus. Development

Christopher Morl

        

Browse more venture capital transactions:

Prev: 11/10/2015: Therabron Therapeutics venture capital transaction
Next: 11/10/2015: Iron Horse Therapeutics venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary